🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: MK-8616

Found 30 matching trials

Rocuronium + Sugammadex vs. Succinylcholine + Cisatracurium + Neostigmine/Atropine in Obese Participants (MK-8616-104)

PHASE4

The primary objective of this trial is to compare the preference between tw...

Status

Withdrawn

Location

Multiple Locations

Start Date

2015-07

Trial ID

NCT02410590

Treatments Being Tested

Rocuronium Sugammadex Cisatracurium Neostigmine/Atropine Succinylcholine

Comparison of Recovery From Rocuronium 1.2 mg/kg Followed by Sugammadex (Org 25969) 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)(MK-8616-026)

PHASE3

The purpose of the trial is to demonstrate a faster recovery from neuromusc...

Status

Completed

Location

Multiple Locations

Start Date

2006-02-10

Trial ID

NCT00474253

Treatments Being Tested

Sugammadex Succinylcholine Rocuronium

Comparing 4.0 mg.Kg-1 Sugammadex With Placebo in the Reversal of Profound Neuromuscular Blockade (P05767)

PHASE3

The current trial was designed to demonstrate faster recovery in participan...

Status

Completed

Location

Multiple Locations

Start Date

2008-10

Trial ID

NCT00758485

Treatments Being Tested

Sugammadex 0.9% sodium chloride (NaCl)

Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)

PHASE4

This trial will evaluate the efficacy, safety, and pharmacokinetics of suga...

Status

Completed

Location

Childrens Hospital Los Angeles ( Site 0030)

Start Date

2018-02-12

Trial ID

NCT03351608

Treatments Being Tested

Sugammadex 2 mg/kg Sugammadex 4 mg/kg Neostigmine + Glycopyrrolate Neostigmine + Atropine

Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017)

PHASE3

The purpose of the trial is to research the safety and to show faster recov...

Status

Completed

Location

Multiple Locations

Start Date

2005-10-27

Trial ID

NCT00475215

Treatments Being Tested

Sugammadex Rocuronium

A Study to Evaluate the Incidence of Hypersensitivity After Administration of Sugammadex in Healthy Participants (MK-8616-101)

PHASE1

The purpose of this study is to assess the potential for hypersensitivity s...

Status

Completed

Location

Multiple Locations

Start Date

2014-01-03

Trial ID

NCT02028065

Treatments Being Tested

Sugammadex Placebo

A Study Comparing the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures in Participants Undergoing Laparoscopic Cholecystectomy (P07982)

PHASE4

The purpose of this pilot study is to compare the use of deep or standard n...

Status

Completed

Location

Merck Sharp & Dohme GmbH

Start Date

2012-11-28

Trial ID

NCT01728584

Treatments Being Tested

Rocuronium Insufflation Sugammadex

Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)

PHASE4

The purpose of this trial is to evaluate the safety and efficacy of Sugamma...

Status

Completed

Location

University California / Davis ( Site 2001)

Start Date

2018-01-01

Trial ID

NCT03346070

Treatments Being Tested

Sugammadex 2 mg/kg ABW Sugammadex 2 mg/kg IBW Sugammadex 4 mg/kg ABW Sugammadex 4 mg/kg IBW Neostigmine + Glycopyrrolate Rocuronium or Vecuronium

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

PHASE4

The purpose of this trial is to evaluate the safety of sugammadex for the r...

Status

Completed

Location

University of Alabama - Birmingham ( Site 1046)

Start Date

2017-12-20

Trial ID

NCT03346057

Treatments Being Tested

Sugammadex 2 mg/kg Sugammadex 4 mg/kg Sugammadex 16 mg/kg Neostigmine + Glycopyrrolate Rocuronium Vecuronium

Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029)

PHASE3

The purpose of the study is to compare the effectiveness, safety and pharma...

Status

Completed

Location

Multiple Locations

Start Date

2005-12-29

Trial ID

NCT00474617

Treatments Being Tested

Sugammadex Rocurium

Previous Next